RecruitingNCT06172491

Harnessing the Power of Technology to Transform Delirium Severity Measurement in the ICU

Sponsor: Mayo Clinic

Trial Details

Condition	Intensive Care Unit Delirium, Encephalopathy, Delirium
Status	Recruiting
Participants	400
Est. Completion	31 May 2027
Last Updated	8 Apr 2026

Primary Outcome

Delirium Severity; Acceptability of passive digital marker for delirium severity; Usability of passive digital marker for delirium severity

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: • Age \>50; * Estimated length of stay \>24 hours in ICU; and * Are not admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal. Exclusion Criteria: * Admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal. * Admitted for acute neuronal injury * Unable to communicate with research team due to sensory deficits (aphasic, blind, deaf) or language (does not speak English)

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

Digital Delirium Monitoring Trial: Mayo Clinic Tests AI-Powered ICU Assessment Tool — Clinical Validation Study Now Recruiting

Mayo Clinic is testing a revolutionary digital monitoring system that uses continuous video analysis to measure delirium severity in ICU patients. This 400-patient observational study could transform how clinicians detect and monitor delirium in critical care settings.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service